Shamano Minhas, MD - Medicare Family Medicine in Skowhegan, ME

Shamano Minhas, MD is a medicare enrolled "Family Medicine" physician in Skowhegan, Maine. His current practice location is 46 Fairview Ave, Skowhegan, Maine. You can reach out to his office (for appointments etc.) via phone at (207) 474-5121.

Shamano Minhas is licensed to practice in Maine (license number MD22665) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1942650809.

Contact Information

Shamano Minhas, MD
46 Fairview Ave,
Skowhegan, ME 04976-1481
(207) 474-5121
(207) 474-3441



Physician's Profile

Full NameShamano Minhas
GenderMale
SpecialityFamily Medicine
Location46 Fairview Ave, Skowhegan, Maine
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1942650809
  • Provider Enumeration Date: 06/21/2016
  • Last Update Date: 09/05/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 6305133117
  • Enrollment ID: I20190628001691

Medical Identifiers

Medical identifiers for Shamano Minhas such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1942650809NPI-NPPES
1942650809MedicaidME

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine MD22665 (Maine)Secondary
390200000XStudent In An Organized Health Care Education/training Program EC161080 (Maine)Secondary
207Q00000XFamily Medicine MD22665 (Maine)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Shamano Minhas allows following entities to bill medicare on his behalf.
Entity NameMainegeneral Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1669423380
PECOS PAC ID: 1254245715
Enrollment ID: O20031118000718

News Archive

Progress in cancer fight, but Congress, States must step up efforts to reduce smoking, lung cancer

Delivering good news for our nation's health, a new report released by the nation's leading cancer organizations finds that, for the first time, both the incidence and death rates for all cancers combined are decreasing for both men and women, driven in part by declines in smoking and lung cancer.

NCI-sponsored study to evaluate rosuvastatin for prevention of colon cancer

With March designated as Colorectal Cancer Awareness Month, the North Shore-LIJ Cancer Institute is enrolling people who were recently treated for colon cancer in a polyp prevention study. This National Cancer Institute (NCI)-sponsored study evaluates the cholesterol drug, rosuvastatin (Crestor), as a treatment to reduce the risk of colon cancer.

Brain structure changes years before dementia or Alzheimer's disease begins

People who develop dementia or Alzheimer's disease experience brain structure changes years before any signs of memory loss begin, according to a study published in the April 17, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.

CEL-SCI receives Polish government approval to commence Multikine Phase III clinical trial in head, neck cancer

CEL-SCI Corporation announced today that it has received approval to begin enrollment of patients in its Phase III clinical trial of Multikine® from the Polish Minister of Health. This approval marks a very important milestone, namely that all nine countries in the study have now given official government approval. Five of about 48 clinical centers for this global trial will be located in Poland.

Researchers use fMRI to observe link between neural activity and risk for obesity

A team of researchers, including senior investigator, Bradley Peterson, MD, director of the Institute for the Developing Mind at Children's Hospital Los Angeles, used fMRI to investigate neural responses to food cues in overweight compared with lean adolescents.

Read more Medical News

› Verified 3 days ago

Entity NameDown East Community Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1689670242
PECOS PAC ID: 6709858194
Enrollment ID: O20040809000314

News Archive

Progress in cancer fight, but Congress, States must step up efforts to reduce smoking, lung cancer

Delivering good news for our nation's health, a new report released by the nation's leading cancer organizations finds that, for the first time, both the incidence and death rates for all cancers combined are decreasing for both men and women, driven in part by declines in smoking and lung cancer.

NCI-sponsored study to evaluate rosuvastatin for prevention of colon cancer

With March designated as Colorectal Cancer Awareness Month, the North Shore-LIJ Cancer Institute is enrolling people who were recently treated for colon cancer in a polyp prevention study. This National Cancer Institute (NCI)-sponsored study evaluates the cholesterol drug, rosuvastatin (Crestor), as a treatment to reduce the risk of colon cancer.

Brain structure changes years before dementia or Alzheimer's disease begins

People who develop dementia or Alzheimer's disease experience brain structure changes years before any signs of memory loss begin, according to a study published in the April 17, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.

CEL-SCI receives Polish government approval to commence Multikine Phase III clinical trial in head, neck cancer

CEL-SCI Corporation announced today that it has received approval to begin enrollment of patients in its Phase III clinical trial of Multikine® from the Polish Minister of Health. This approval marks a very important milestone, namely that all nine countries in the study have now given official government approval. Five of about 48 clinical centers for this global trial will be located in Poland.

Researchers use fMRI to observe link between neural activity and risk for obesity

A team of researchers, including senior investigator, Bradley Peterson, MD, director of the Institute for the Developing Mind at Children's Hospital Los Angeles, used fMRI to investigate neural responses to food cues in overweight compared with lean adolescents.

Read more Medical News

› Verified 3 days ago

Entity NameEmergency Medicine Services Of Maine Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1578032058
PECOS PAC ID: 1052657616
Enrollment ID: O20190118000889

News Archive

Progress in cancer fight, but Congress, States must step up efforts to reduce smoking, lung cancer

Delivering good news for our nation's health, a new report released by the nation's leading cancer organizations finds that, for the first time, both the incidence and death rates for all cancers combined are decreasing for both men and women, driven in part by declines in smoking and lung cancer.

NCI-sponsored study to evaluate rosuvastatin for prevention of colon cancer

With March designated as Colorectal Cancer Awareness Month, the North Shore-LIJ Cancer Institute is enrolling people who were recently treated for colon cancer in a polyp prevention study. This National Cancer Institute (NCI)-sponsored study evaluates the cholesterol drug, rosuvastatin (Crestor), as a treatment to reduce the risk of colon cancer.

Brain structure changes years before dementia or Alzheimer's disease begins

People who develop dementia or Alzheimer's disease experience brain structure changes years before any signs of memory loss begin, according to a study published in the April 17, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.

CEL-SCI receives Polish government approval to commence Multikine Phase III clinical trial in head, neck cancer

CEL-SCI Corporation announced today that it has received approval to begin enrollment of patients in its Phase III clinical trial of Multikine® from the Polish Minister of Health. This approval marks a very important milestone, namely that all nine countries in the study have now given official government approval. Five of about 48 clinical centers for this global trial will be located in Poland.

Researchers use fMRI to observe link between neural activity and risk for obesity

A team of researchers, including senior investigator, Bradley Peterson, MD, director of the Institute for the Developing Mind at Children's Hospital Los Angeles, used fMRI to investigate neural responses to food cues in overweight compared with lean adolescents.

Read more Medical News

› Verified 3 days ago

Entity NameCalais Community Hospital
Entity TypePart B Supplier - Hospital Department(s)
Entity IdentifiersNPI Number: 1922001049
PECOS PAC ID: 0345649158
Enrollment ID: O20210910001201

News Archive

Progress in cancer fight, but Congress, States must step up efforts to reduce smoking, lung cancer

Delivering good news for our nation's health, a new report released by the nation's leading cancer organizations finds that, for the first time, both the incidence and death rates for all cancers combined are decreasing for both men and women, driven in part by declines in smoking and lung cancer.

NCI-sponsored study to evaluate rosuvastatin for prevention of colon cancer

With March designated as Colorectal Cancer Awareness Month, the North Shore-LIJ Cancer Institute is enrolling people who were recently treated for colon cancer in a polyp prevention study. This National Cancer Institute (NCI)-sponsored study evaluates the cholesterol drug, rosuvastatin (Crestor), as a treatment to reduce the risk of colon cancer.

Brain structure changes years before dementia or Alzheimer's disease begins

People who develop dementia or Alzheimer's disease experience brain structure changes years before any signs of memory loss begin, according to a study published in the April 17, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.

CEL-SCI receives Polish government approval to commence Multikine Phase III clinical trial in head, neck cancer

CEL-SCI Corporation announced today that it has received approval to begin enrollment of patients in its Phase III clinical trial of Multikine® from the Polish Minister of Health. This approval marks a very important milestone, namely that all nine countries in the study have now given official government approval. Five of about 48 clinical centers for this global trial will be located in Poland.

Researchers use fMRI to observe link between neural activity and risk for obesity

A team of researchers, including senior investigator, Bradley Peterson, MD, director of the Institute for the Developing Mind at Children's Hospital Los Angeles, used fMRI to investigate neural responses to food cues in overweight compared with lean adolescents.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Shamano Minhas is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Shamano Minhas, MD
46 Fairview Ave,
Skowhegan, ME 04976-1481

Ph: (207) 474-5121
Shamano Minhas, MD
46 Fairview Ave,
Skowhegan, ME 04976-1481

Ph: (207) 474-5121

News Archive

Progress in cancer fight, but Congress, States must step up efforts to reduce smoking, lung cancer

Delivering good news for our nation's health, a new report released by the nation's leading cancer organizations finds that, for the first time, both the incidence and death rates for all cancers combined are decreasing for both men and women, driven in part by declines in smoking and lung cancer.

NCI-sponsored study to evaluate rosuvastatin for prevention of colon cancer

With March designated as Colorectal Cancer Awareness Month, the North Shore-LIJ Cancer Institute is enrolling people who were recently treated for colon cancer in a polyp prevention study. This National Cancer Institute (NCI)-sponsored study evaluates the cholesterol drug, rosuvastatin (Crestor), as a treatment to reduce the risk of colon cancer.

Brain structure changes years before dementia or Alzheimer's disease begins

People who develop dementia or Alzheimer's disease experience brain structure changes years before any signs of memory loss begin, according to a study published in the April 17, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.

CEL-SCI receives Polish government approval to commence Multikine Phase III clinical trial in head, neck cancer

CEL-SCI Corporation announced today that it has received approval to begin enrollment of patients in its Phase III clinical trial of Multikine® from the Polish Minister of Health. This approval marks a very important milestone, namely that all nine countries in the study have now given official government approval. Five of about 48 clinical centers for this global trial will be located in Poland.

Researchers use fMRI to observe link between neural activity and risk for obesity

A team of researchers, including senior investigator, Bradley Peterson, MD, director of the Institute for the Developing Mind at Children's Hospital Los Angeles, used fMRI to investigate neural responses to food cues in overweight compared with lean adolescents.

Read more News

› Verified 3 days ago


Family Medicine Doctors in Skowhegan, ME

Laura Gurenlian, DO
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 46 Fairview Ave, Skowhegan, ME 04976
Phone: 207-474-5121    Fax: 207-474-3441
Florence Dasrath, MD
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 46 Fairview Ave Ste 334, Skowhegan, ME 04976
Phone: 207-474-6201    Fax: 207-474-0969
Andreas Jeremy Thimm, M.D.
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 64 Fairview Ave, Skowhegan, ME 04976
Phone: 207-474-6201    
Dr. Donald W Zarfos, M.D.
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 46 Fairview Ave, Skowhegan, ME 04976
Phone: 207-474-5121    
Nancy E Fleming, MD
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 46 Fairview Ave, Skowhegan, ME 04976
Phone: 207-474-5121    Fax: 207-474-3441
Cathal Kavanagh, DO
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 46 Fairview Ave, Suite 111, Skowhegan, ME 04976
Phone: 207-474-0905    Fax: 207-474-6930
Michael H Lambke, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 46 Fairview Ave Ste 334, Skowhegan, ME 04976
Phone: 207-474-6201    Fax: 207-474-0969

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.